No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
AKTX Akari Therapeutics
- 0.8990
- -0.0010-0.11%
Close Mar 11 16:00 ET
- 0.8700
- -0.0290-3.23%
Post 16:24 ET
23.80MMarket Cap-0.35P/E (TTM)
0.9635High0.8990Low17.80KVolume0.9500Open0.9000Pre Close16.70KTurnover0.13%Turnover RatioLossP/E (Static)26.47MShares4.400052wk High-3.55P/B12.18MFloat Cap0.850052wk Low--Dividend TTM13.55MShs Float5000.0000Historical High--Div YieldTTM7.17%Amplitude0.8500Historical Low0.9370Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Akari Therapeutics Announces $7.6M Private Placement Offering Led By Existing Shareholders And Insiders Of 6,637,626 Unregistered American Depository Shares At A Price Of $0.87 Per ADS
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
Akari Therapeutics Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand
Akari Therapeutics Joins Webull Corporate Connect Service Platform
ADRs End Lower; Akari Therapeutics PLC Declines 19%